ALPN

ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

By Matthew Farley, InvestorPlace Contributor Apr 15, 2024

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.

By Dana Blankenhorn, InvestorPlace Contributor Apr 11, 2024

Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.

By William White, InvestorPlace Writer Apr 11, 2024

We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!

By InvestorPlace Earnings Mar 18, 2024

ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

By William White, InvestorPlace Writer Sep 22, 2021

Good morning, investor! We're halfway through the week and starting off Wednesday with a look at the biggest pre-market stock movers today.